Skip to main content
. 2020 Feb 13;11:822. doi: 10.1038/s41467-020-14551-2

Fig. 1. Establishing a biobank of ovarian cancer ex vivo models.

Fig. 1

a Patient timelines showing age at diagnosis and death, treatments and biopsy collections. b Workflow for processing and storage of stromal and tumour fractions. (RBC red blood cells, WBC white blood cells, LN2 and −80 °C specifies long-term storage, OCMI ovarian carcinoma modified Ince medium, NGS next-generation sequencing, VEGFi vascular endothelial growth factor inhibitor). See also Supplementary Fig. 1 and Supplementary Tables 1 and 2.